The communication between Notch and EGFR signaling may lead to more aggressive disease due to acquired resistance to EGFR-targeted chemotherapeutics through enhanced EMT characteristics (Xie et al., 2013), a behavior often associated with cancer aggressiveness. The gene discussed is EGFR; the disease is cancer.